Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Hahn

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|June 28, 2021
Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Controlling Nutritional Status Score?Lukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Cancers|August 27, 2021
Refining Prognosis in Chemoembolization for Hepatocellular Carcinoma: Immunonutrition and Liver FunctionLukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Cancers|October 13, 2021
Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY IndexLukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Journal of Clinical Medicine|August 27, 2021
Liver Resection for Intrahepatic Cholangiocarcinoma-Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year PeriodHauke Lang, Janine Baumgart, Stefan Heinrich, et al.
Journal of Clinical Medicine|July 2, 2021
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic CholangiocarcinomaSimon Johannes Gairing, Felix Thol, Lukas Müller, et al.
Plos One|August 22, 2025
Bone mineral density predicts survival in patients with hepatocellular carcinoma and portal vein tumor thrombosisLukas Müller, Roman Kloeckner, Lorena Heim, et al.
Frontiers in Oncology|March 14, 2022
Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring SystemsLukas Müller, Felix Hahn, Timo Alexander Auer, et al.
United European Gastroenterology Journal|December 17, 2021
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationLukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Biomedicines|September 28, 2023
Change in Splenic Volume as a Surrogate Marker for Immunotherapy Response in Patients with Advanced Urothelial and Renal Cell Carcinoma-Evaluation of a Novel Approach of Fully Automated Artificial Intelligence Based Splenic SegmentationGregor Duwe, Lukas Müller, Christian Ruckes, et al.
Plos One|September 21, 2021
How COVID-19 kick-started online learning in medical education-The DigiMed studyFabian Stoehr, Lukas Müller, Adrian Brady, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|June 28, 2021
Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Controlling Nutritional Status Score?Lukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Cancers|August 27, 2021
Refining Prognosis in Chemoembolization for Hepatocellular Carcinoma: Immunonutrition and Liver FunctionLukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Cancers|October 13, 2021
Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY IndexLukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Journal of Clinical Medicine|August 27, 2021
Liver Resection for Intrahepatic Cholangiocarcinoma-Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year PeriodHauke Lang, Janine Baumgart, Stefan Heinrich, et al.
Journal of Clinical Medicine|July 2, 2021
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic CholangiocarcinomaSimon Johannes Gairing, Felix Thol, Lukas Müller, et al.
Plos One|August 22, 2025
Bone mineral density predicts survival in patients with hepatocellular carcinoma and portal vein tumor thrombosisLukas Müller, Roman Kloeckner, Lorena Heim, et al.
Frontiers in Oncology|March 14, 2022
Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring SystemsLukas Müller, Felix Hahn, Timo Alexander Auer, et al.
United European Gastroenterology Journal|December 17, 2021
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationLukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Biomedicines|September 28, 2023
Change in Splenic Volume as a Surrogate Marker for Immunotherapy Response in Patients with Advanced Urothelial and Renal Cell Carcinoma-Evaluation of a Novel Approach of Fully Automated Artificial Intelligence Based Splenic SegmentationGregor Duwe, Lukas Müller, Christian Ruckes, et al.
Plos One|September 21, 2021
How COVID-19 kick-started online learning in medical education-The DigiMed studyFabian Stoehr, Lukas Müller, Adrian Brady, et al.
Pageof 6